resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.
RESEARCH & INNOVATION
transforming pediatric health care
Endocrinology
Emerging research drives new era in pediatric achondroplasia care
Explore how Children’s Health collaborated on new achondroplasia care guidelines, offering endocrinologists actionable advice on vosoritide therapy, early risks and improving family support.
Endocrinology
Pilot program helps teens meet health goals after bariatric surgery
Children’s Health is piloting a lifestyle intervention program, called TeenLYFT, to support adolescents who undergo bariatric surgery. The service provides individualized resources to help maintain a healthy diet, vitamin regimen and exercise routine.
Endocrinology
GLP-1RAs show promise in addressing pediatric obesity and MASLD
As obesity and metabolic dysfunction-associated steatotic liver (MDSL) disease rise, Children’s Health is pioneering the use of GLP-1 receptor agonists in adolescents. Backed by a new clinical algorithm, these therapies offer hope.
Endocrinology
Characterizing pediatric obesity at the cellular level
Novel research at Children’s Health is using single-cell RNA sequencing to explore the nuances of pediatric obesity at the cellular level, and hopefully, fuel personalized medicine approaches. Learn early insights.
Endocrinology, +1 more
Case Study: Life-Changing Care for a Teen with Complex Congenital Adrenal Hyperplasia
As one of only eight CAH Centers of Excellence nationwide, the center at Children’s Health is led by two renowned UT Southwestern physicians. The center has a Level I designation by the CARES Foundation.
Endocrinology
New treatment for Stage 2 T1D helps delay onset of Stage 3 T1D
A monoclonal antibody called Tzield gives children with Stage 2 type 1 diabetes the chance to delay the onset of symptoms and the need for insulin therapy. Learn why Tzield is a game-changer and what to know about screening and other details.
Endocrinology
New drug trial for familial chylomicronemia syndrome (FCS)
Children’s Health Lipid Disorders Program is the only one in the country enrolling children with familial chylomicronemia syndrome into a clinical trial for orlistat. Our pediatric endocrinologist answers questions about the trial and how to enroll.
Endocrinology
Identifying risk factors for adverse outcomes in children with diabetic ketoacidosis
Endocrinologists at Children’s Health assessed clinical data to identify risk factors, which is informing patient care and improving outcomes for children with diabetes.
Endocrinology
NCT06129539
This is an open-label, single-arm, multi-center, Phase 3 study of Debio 4326, a triptorelin acetate 70 mg, 12-month extended-release formulation, in pediatric participants with central (gonadotropin-dependent) precocious puberty (CPP).
Endocrinology
NCT05743244
This phase 2 trial is a double-blind, randomized, placebo-controlled clinical trial in male and female adolescent and adult participants (ages 12-35 years) with newly diagnosed Stage 3 T1D (within 100 days of diagnosis).
Endocrinology
NCT05493709
The study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with central (gonadotropin-dependent) precocious puberty, when administered as two injections six months apart.
Endocrinology
NCT03929601
The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr alone in new onset T1D.
Endocrinology
NCT04540536
We will conduct a pilot study, which will enroll 20 adolescents age 13-18 years with Type 1 Diabetes duration for at least 6 months managed with insulin who have poor glycemic control.
Endocrinology
A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children with Classic 21-Hydroxylase Deficiency
This study seeks to use oral abiraterone acetate(Zytiga)as an adjunct to approved CAH therapy (oral hydrocortisone and fludrocortisone) for pre-pubescent children with classic 21-hydroxylase deficiency in order to reduce daily requirement of hydrocortisone